Argenx brews up DTC push for Vyvgart Hytrulo prefilled syringe in generalized myasthenia gravis
8th May 2025 Uncategorised 0Fresh off earning FDA approval for a prefilled syringe version of Vyvgart Hytrulo for at-home administration, argenx is building buzz with a new direct-to-consumer campaign.
More: Argenx brews up DTC push for Vyvgart Hytrulo prefilled syringe in generalized myasthenia gravis
Source: fierce
